Jubilant Pharmova Ltd is an integrated global pharmaceuticals company having three business segments i.e. pharmaceuticals, contract research and development services and proprietary novel drugs.
Financial Results:
- Jubilant Pharmova Ltd reported Revenues for Q1 FY24 of ₹1,586.90 Crores up from ₹1,451.70 Crore year on year, a rise of 9.31%.
- Total Expenses for Q1 FY24 of ₹1,570.30 Crores up from ₹1,393.90 Crores year on year, a rise of 12.66%.
- Consolidated Net Profit of ₹6.00 Crores down 87.18% from ₹46.80 Crores in the same quarter of the previous year.
- The Earnings per Share is ₹0.40, down 86.49% from ₹2.96 in the same quarter of the previous year.
*It is important to note that the way the results have been accounted for are slightly different than the ones the companies may choose to publish.
*The presented data is automatically generated. It may occasionally generate incorrect information.